太阳光的太阳镜:对耐火性结肠直肠癌的新治疗机会的考虑
1Oncologia Medica, Fondazione Poliambulanza, 25124 Brescia, Italy.
Cancers
|April 13, 2024
概括
两项2023年的研究扩大了耐火转移性结直肠癌 (MCRC) 的治疗选择. 这些发现为患有晚期疾病的患者提供了新的希望.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 耐火性转移性结肠直肠癌 (MCRC) 存在重大治疗挑战.
- 对于患有晚期MCRC的患者,治疗选择有限.
研究的目的:
- 审查MCRC的药理治疗中最近的进展.
- 突出两项2023年开创性研究的关键发现.
主要方法:
- 最近临床试验和研究的文献综述.
- 对MCRC的药理学药剂和治疗策略的分析.
主要成果:
- 在2023年发表的两项重要的研究引入了新的治疗方法.
- 这些研究表明,对MCRC有增强的药理选择.
结论:
- 最近的进展扩大了耐火MCRC的治疗领域.
- 新的药理学策略为晚期结直肠癌患者提供了更好的前景.
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Therapies
7.6K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.6K


